Literature DB >> 15179978

Pharmaceuticals in U.S. health care: determinants of quantity and price.

Ernst R Berndt1.   

Abstract

Mesh:

Year:  2002        PMID: 15179978     DOI: 10.1257/089533002320950975

Source DB:  PubMed          Journal:  J Econ Perspect        ISSN: 0895-3309


× No keyword cloud information.
  12 in total

1.  Market power and state costs of HIV/AIDS drugs.

Authors:  Arleen A Leibowitz; Neeraj Sood
Journal:  Int J Health Care Finance Econ       Date:  2007-05-05

2.  The effect of pharmaceutical patent term length on research and development and drug expenditures in Canada.

Authors:  Paul Grootendorst; Livio Di Matteo
Journal:  Healthc Policy       Date:  2007-02

3.  Generic script share and the price of brand-name drugs: the role of consumer choice.

Authors:  John A Rizzo; Richard Zeckhauser
Journal:  Int J Health Care Finance Econ       Date:  2009-01-08

4.  Analysis of US Food and Drug Administration Warning Letters: False Promotional Claims Relating to Prescription and Over-the-Counter Medications.

Authors:  Maribel Salas; Michelle Martin; Maria Pisu; Erin McCall; Alvaro Zuluaga; Stephen P Glasser
Journal:  Pharmaceut Med       Date:  2008-03-01

5.  Pharmaceutical risk-sharing agreements.

Authors:  Joseph P Cook; John A Vernon; Richard Manning
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

6.  Generic substitution: micro evidence from register data in Norway.

Authors:  Dag Morten Dalen; Kari Furu; Marilena Locatelli; Steinar Strøm
Journal:  Eur J Health Econ       Date:  2010-03-06

7.  Understanding profit margins of medical providers from prescription drugs: evidence from Taiwan.

Authors:  Ya-Ming Liu
Journal:  Int Health       Date:  2020-07-01       Impact factor: 2.473

8.  Impacts of drug reimbursement reductions on utilization and expenditures of oral antidiabetic medications in Taiwan: an interrupted time series study.

Authors:  Jason C Hsu; Christine Y Lu; Anita K Wagner; K Arnold Chan; Mei-Shu Lai; Dennis Ross-Degnan
Journal:  Health Policy       Date:  2013-11-20       Impact factor: 2.980

9.  A Prescription for Drug Formulary Evaluation: An Application of Price Indexes.

Authors:  Jacob Glazer; Haiden A Huskamp; Thomas G McGuire
Journal:  Forum Health Econ Policy       Date:  2012-03-30

10.  Assessing different perspectives on the value of a pharmaceutical innovation.

Authors:  Albert Wertheimer; Larry Radican; Michael Robert Jacobs
Journal:  South Med Rev       Date:  2010-02-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.